Jeffrey Conn

The Center for Technology Transfer and Commercialization is taking Vanderbilt researchers’ inventions to new heights An array of instruments and gadgets found in the Olin Hall laboratory of Professor of Mechanical Engineering Michael Goldfarb. (John Russell/Vanderbilt) Use the term “inventor,” and what pops to mind? The wild-haired Dr. Emmett… Read More

Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read More

The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia. Read More

Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism. Read More

Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain. Read More